Cancer News and Research

Latest Cancer News and Research

Novel targeted therapy may be an effective treatment option for neuroblastoma

New research from VCU Massey Cancer Center - published Thursday in Cell Reports - demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known as neuroblastoma.

28 Jul 2022

Transplant remains the standard of care for liver cancer patients, regardless of age

Physicians and researchers from UK HealthCare's Transplant Center and the University of Kentucky Markey Cancer Center conducted a study of patients over the age of 70 with a type of liver cancer called hepatocellular carcinoma (HCC) and how the outcomes of ablative treatments compare to liver transplants.

28 Jul 2022

New discovery may open the door to targeted treatments for two types of rhabdomyosarcoma

A gene that UVA Health researchers discovered is responsible for the deadliest type of brain tumor is also responsible for two forms of childhood cancer, the scientists have found.

28 Jul 2022

Study shows efficacy and safety of cytisine as a smoking cessation therapy

Research published in the Journal of Thoracic Oncology shows cytisine may be a safe and effective smoking cessation therapy in lung cancer screening volunteers.

28 Jul 2022

Oncology trial data not available for independent scrutiny, study finds

Despite a commitment from the pharmaceutical industry in 2014 to improve data transparency, more than half of the clinical trials that led to the United States Food and Drug Administration approving anticancer medicines over the past 10 years are not available for independent scrutiny, a multi-national study led by Flinders University has found.

28 Jul 2022

Repurposing an antipsychotic drug to treat various types of cancer

To treat some of the psychosis issues associated with Parkinson's disease, physicians often prescribe pimavanserin, an antipsychotic drug that acts within the brain to prevent hallucinations and delusions.

28 Jul 2022

The role of cellular or cytokine response and vaginal microbiome dysbiosis in the clearance, persistence, and recurrence of HPV infection

Researchers have reviewed the role of cytokine or cellular response and vaginal microbiome dysbiosis in the persistence, clearance, and recurrence of HPV infection

28 Jul 2022

Everything you need to know about Paxlovid — especially, should you take it?

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid.

28 Jul 2022

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

28 Jul 2022

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Researchers estimated the years of life lost during the COVID-19 pandemic in the United States.

28 Jul 2022

Mesoporous silica nanoparticles: Possibilities in therapeutic development

In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.

From nanoComposix 28 Jul 2022

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

In mouse studies, researchers at University of California San Diego School of Medicine report that lactating mothers expose their feeding pups to triclosan, an antimicrobial commonly used in consumer products, resulting in early signs of liver damage that can eventually lead to more serious impairment and illness, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

28 Jul 2022

An enzyme may be a potent new tool for reducing nitrous oxide in the atmosphere

An enzyme that combats the greenhouse gas nitrous oxide (N2O) may one day give scientists a potent new tool for reducing the amount of the gas in the atmosphere thanks in part to new findings published today in Nature.

28 Jul 2022

Researchers unravel how one gut bacterium influences immunity

From immunity to metabolism to mental health, it seems like the gut microbiome has been linked to every aspect of human health and disease.

27 Jul 2022

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Researchers at the Francis Crick Institute have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics.

27 Jul 2022

Epigenetic age acceleration could be used as a biomarker to estimate functional and cognitive aging

A first-of-its-kind study of 1,813 older women suggests that the accelerated biological aging of the body - epigenetic age acceleration specifically - is associated with lower odds of living to be 90 years old and also being physically mobile and having intact mental function.

27 Jul 2022

Cancer News and Research

Latest Cancer News and Research

Novel targeted therapy may be an effective treatment option for neuroblastoma

Transplant remains the standard of care for liver cancer patients, regardless of age

New discovery may open the door to targeted treatments for two types of rhabdomyosarcoma

Study shows efficacy and safety of cytisine as a smoking cessation therapy

Oncology trial data not available for independent scrutiny, study finds

Repurposing an antipsychotic drug to treat various types of cancer

The role of cellular or cytokine response and vaginal microbiome dysbiosis in the clearance, persistence, and recurrence of HPV infection

Everything you need to know about Paxlovid — especially, should you take it?

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Mesoporous silica nanoparticles: Possibilities in therapeutic development

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

An enzyme may be a potent new tool for reducing nitrous oxide in the atmosphere

Researchers unravel how one gut bacterium influences immunity

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Epigenetic age acceleration could be used as a biomarker to estimate functional and cognitive aging

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

New method could lead to more efficient production of next-generation antibiotics

Research can pave the way for early detection of biliary tract cancer

Hearing issues often occur among adult cancer survivors, study reports

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in